-
Osobe Vidi sve
Ovjeren akaunt@Catapult_UK Catapults are a rapidly growing network of
#technology centres, established by@innovateuk with over £1bn of UK government#funding &#innovation#investment. -
Been waiting for this one to drop for a while now. Well worth the wait! Huge congrats to Katy and the team
@MDAndersonNews The future of Allo CAR NK cells is so bright
@oNKo_innate@NEJM#nkcell#immunotherapy#cancer#celltherapy https://twitter.com/LabFehniger/status/1223721334628323332 …
-
Congratulations to the
#Precigen team and our new shareholders for the start of a new chapter. We look forward to continuing to live by our brand promise to advance medicine with precision.$PGEN@nasdaq#Maryland#GeneTherapy#CellTherapy#Immunotherapy https://bit.ly/391JDLi pic.twitter.com/VhepwI0wLm
-
Breaking: Catalent
$CTLT to buy Orgenesis'#celltherapy#CDMO biz Masthercell for $315m - story@BioProInsider Insider https://buff.ly/36PRRod pic.twitter.com/gdXg2Jb6nZ
-
Sign up to our monthly newsletter featuring the latest
#celltherapy#genetherapy news, publications and events, being the first to find out about recently released reports and initiatives for accelerating patient access to#advancedtherapies.
http://ow.ly/HHig50xB2JR pic.twitter.com/rErq5xAtv2
-
@avacta today announced a collaboration & license agreement with AffyXell Therapeutics, its joint venture with Daewoong Pharmaceutical, to develop Affimer proteins to be used by AffyXell for the generation of new#celltherapy and#genetherapy https://avacta.com/avacta-and-daewoong-agree-collaboration-and-license-agreement-with-affyxell-therapeutics/ …#biotech -
Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform Read more: http://ow.ly/jawX50ybOMV
#pressrelease#celltherapy pic.twitter.com/BfpOGHkxz3
-
Orgenesis sells Masthercell Global, its contract development and manufacturing organisation subsidiary. Will use $127 million to continue to grow its point-of-care
#celltherapy business and to further the development of its#ATMPs. https://tinyurl.com/whfbu7u -
Register for our exclusive Bioanalysis Zone Coffee Chat focusing on developments in cell and gene therapies featuring Frontage's expert, Weiping Shao!
#CellTherapy#GeneTherapy Register, here: http://bit.ly/2Uw5nLt pic.twitter.com/Y3s6HZ8lyD
-
“(Self) Clapping in water no body leaking distraction.” “(Shelf) Slapping din theater go parody speaking attraction.”
@physorg_com@MonashUni@museumsvictoria@UniofNewcastle@NHM_London@Te_Papa#leaks#celltherapy#clapyourhandchallengepic.twitter.com/6ld2ffHwsT
-
“Leaking neighbors vehicle pressures.” “Tweaking harbours particle measures.”
@sanatron_llc#Hidden#leaks#celltherapy pic.twitter.com/4m4lemrQ1H
-
Congratulations
@drghildebrandt - seems like this was
#BMT#CellTherapy program + really excited to see many trainees and junior faculty coming into the field;
for your mentorship and coaching -
Check out and follow our new sister project
@AutoCRAT2020#automation#MSCs#EVs#celltherapy#osteoarthritispic.twitter.com/xNbXGdFkSg
-
#CellTherapy When you start to doubt where it is that you are going take a moment to think about how far you have come.. I Am S.C. Yatta Follow me on Facebook Instagram and Twitter @ S.C. Yatta -
If we had a boxing team we’d be state champion’s!!
#celltherapy -
Lineage is developing a novel
#celltherapy to treat dry age-related macular degeneration (#AMD), the leading cause of irreversible vision loss in the US. OpRegen is currently in Phase I/IIa and has the potential to help many patients. https://investor.lineagecell.com/news-releases/news-release-details/lineage-provides-update-patient-enrollment-phase-iiia-clinical …pic.twitter.com/hxZ6YjG9v3
-
Love the fresh clod weather and view..
#Switzerland#Photos#CellTherapy pic.twitter.com/Yg9Yb18Hz9
-
We are excited to announce that the first patient in the Ph1
#ClinicalTrial evaluating our autologous#CellTherapy comprised of SQZ-engineered APCs for HPV+ tumors has started treatment. Click here to read more about this pivotal company milestone: http://bit.ly/36HUHeS pic.twitter.com/Scuxk4tgz4
-
Here's the intro post of our new blog series focusing on Advanced Therapy Medicinal Products (ATMPs): regulation, reimbursement, manufacturing, clinical studies, ...
Read blogpost => http://bit.ly/38J0N06 #personalizedmedicine#atmp#celltherapy pic.twitter.com/nQaCdLb7S0
-
Attended the Advanced Therapies Programme Board this afternoon, amazing to see the progress in Cell+Gene therapies since I last did some work in this area 2 years ago. Products in market and trials taking place in Cardiff at the cutting edge of new treatments
#celltherapy@CV_UHB -
Fantastic to see that advanced therapies are a key element to the recently updated government life sciences strategy and the ATTCs feature as a delivery vehicle for this strategy https://www.theattcnetwork.co.uk/news/advanced-therapies-a-key-element-of-uk-government-life-sciences-strategy …
@AttcMw@naattc#ATMP#genetherapy#celltherapy
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.